What is Bicara Therapeutics's shares (basic)?

Bicara Therapeutics (BCAX) reported shares (basic) of 60.7M in Q1 2026.

How has Bicara Therapeutics's shares (basic) changed year-over-year?

Bicara Therapeutics's shares (basic) increased by 11.5% year-over-year, from 54.5M to 60.7M.

What does shares (basic) mean?

The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.

Bicara Therapeutics BCAX Shares (Basic)

Shares (Basic) at other companies

Eli LillyLLY

894.5M-0.5%

AmgenAMGN

540M+0.4%

ArriVent BioPharma, Inc.AVBP

45.1M+32.9%

ImmunomeIMNM

113.1M+42.5%

Arcus BiosciencesRCUS

125.4M+27.4%

Syndax PharmaceuticalsSNDX

88.3M+2.4%

Other financials

Income statement

See full

Operating income-$60.2M-44.2%

Net income-$56.2M-52.6%

EPS (diluted)-$0.93-36.8%

Balance sheet

See full

Cash & equivalents$323.5M-30.0%

Total debt$1.4M+144%

Total equity$514.0M+12.0%

Total assets$553.6M+15.8%

Cash flow

See full

Operating cash flow-$37.5M-33.5%

CapEx$60.0K—

Free cash flow-$37.6M-33.7%

Valuation

See full

Market cap$1.68B+81.4%

Returns & leverage

See full

Return on equity-32.3%—

Debt / equity0×0.0×

Current ratio13.9×-10.8×

Where this comes from

Reported directly by Bicara Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bicara Therapeutics's shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bicara Therapeutics's shares (basic)?: Bicara Therapeutics (BCAX) reported shares (basic) of 60.7M in Q1 2026.
How has Bicara Therapeutics's shares (basic) changed year-over-year?: Bicara Therapeutics's shares (basic) increased by 11.5% year-over-year, from 54.5M to 60.7M.
What does shares (basic) mean?: The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.